Debut Plus

₹98.94

▲ +1.94 +2.00%

17 Jul 2026

BSE Listed

GSM 0 · ESM 2

Parmax Pharma Limited (540359)

Volume: 5,492Avg Vol 1W: 23,209Avg Vol 1M: 9,55852W Range:₹22.6₹98.94
BSE www.parmaxpharma.com
Key Ratios
Checked 1h ago
Market Cap₹37 Cr
Current Price₹98.94
Previous Close₹97
High / Low (52w)₹98.94 / ₹22.6
Volume5,492
Avg Vol (1W)23,209
Avg Vol (1M)9,558
Stock P/E—
Book Value₹-18.33
Dividend Yield0%
ROE67.65%
ROA-14.8%
Revenue (TTM)—
Revenue Growth—
Profit Margin-34.27%
Total Debt—
Shares Outstanding0 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹58.24
200 DMA₹38.71
Day change+2.00%
SurveillanceGSM 0 · ESM 2 (as of 2026-07-16)
Price Chart
₹98.94▲ 143.69% · 1Y
₹99₹2592K
2025-07-16
2026-07-16

20-day avg volume: 10K shares

Pros
  • Healthy return on equity of 67.7%.
  • Company is almost debt-free.
  • Revenue grew 154% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹8 Cr₹9 Cr₹6 Cr₹5 Cr₹2 Cr₹3 Cr₹4 Cr₹3 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-2 Cr₹0 Cr₹-2 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹-1 Cr₹-1 Cr₹-2 Cr₹-1 Cr₹-1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹12 Cr₹12 Cr₹21 Cr₹26 Cr₹18 Cr₹15 Cr₹11 Cr₹28 Cr
EBITDA₹0 Cr₹0 Cr₹1 Cr₹2 Cr₹1 Cr₹0 Cr₹-5 Cr₹-1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹-6 Cr₹-2 Cr
EPS00.211.152.020.38-0.28-34.56-5.6
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹17 Cr₹20 Cr₹21 Cr₹23 Cr₹18 Cr₹18 Cr₹15 Cr₹19 Cr
Total Liabilities₹12 Cr₹15 Cr₹16 Cr₹17 Cr₹12 Cr₹12 Cr₹15 Cr₹21 Cr
Equity₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹6 Cr₹0 Cr₹-2 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹4 Cr₹1 Cr₹0 Cr₹0 Cr₹-1 Cr
Investing₹-3 Cr₹-2 Cr₹-1 Cr₹-2 Cr₹-1 Cr
Financing₹0 Cr₹-1 Cr₹0 Cr₹1 Cr₹1 Cr
Free Cash Flow₹4 Cr₹1 Cr₹0 Cr₹0 Cr₹-1 Cr
Shareholding
Promoter 30.8% Institutions 0% Public 69.2%
Efficiency & Working Capital
ROCE-85.8%
Interest Coverage-1.2
Dividend Payout—
Debtor Days17 d
Inventory Days43 d
Payable Days132 d
Cash Conversion Cycle-73 d
Working Capital Days59 d
Shareholding Details

As of 2026-03-31

Promoter30.8%
FII0%
DII0%
Institutions0%
Public69.2%
Promoter Pledge0%
No. of Shareholders2,388
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%30.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%69.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,9781,9732,0022,0992,1852,2462,3342,3562,3772,3992,3932,388
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Alkesh Mahasukhlal GopaniShareholding of Promoter and Promoter Group17.9%6,70,380
Vipul Mahasukhlal GopaniShareholding of Promoter and Promoter Group12.9%4,81,370
Gosalia Meena AlkeshPublic Shareholding12.7%4,74,800
Pradeep Ramniklal GosaliaPublic Shareholding8.1%3,02,714
Umang Alkesh GosaliaPublic Shareholding5.4%2,00,000
Gosalia Nimit PPublic Shareholding2.4%90,000
Vandana Pradeepbhai GosaliaPublic Shareholding1.2%42,949
Bharti Deepak MehtaPublic Shareholding1.1%42,816
Pravina Mahasukhlal GopaniShareholding of Promoter and Promoter Group0%700
Mahasukhlal GopaniShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Mahasukhlal Gopani00%2026-03-31
Pravina Mahasukhlal Gopani00%2026-03-31
Alkesh Mahasukhlal Gopani00%2026-03-31
Vipul Mahasukhlal Gopani00%2026-03-31
Umang Alkesh Gosalia00%2026-03-31
Pradeep Ramniklal Gosalia00%2026-03-31
Vandana Pradeepbhai Gosalia00%2026-03-31
Gosalia Nimit P00%2026-03-31
Gosalia Meena Alkesh00%2026-03-31
Bharti Deepak Mehta00%2026-03-31
Mahasukhlal Gopani00%2025-12-31
Pravina Mahasukhlal Gopani00%2025-12-31
Board of Directors
NameDesignationYear
Umang Alkesh GosaliaExecutive Director & MD2025
Ami R ShahIndependent Non Exe. Director2025
Nikhil S. UchatIndependent Non Exe. Director2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10654
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500000—
2025000001
2025000001
Substantial Acquisitions (SAST)

1 disclosure(s)

NULL01/12/2021 · 3,81,170
Company Information
Incorporated1994
AuditorB A Shah S R Mehta & Co
Investor Email[email protected]
🌐 www.parmaxpharma.com ↗

📍 Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala, Rajkot, Gujarat, 360311

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Super Fine Knitters LimitedRaideep Industries LimitedClassic Filaments LimitedJITF InfralogisticsSueryaa Knitwear LimitedTanvi Foods (India) LimitedLeading Leasing Finance ADanube Industries LimitedIFL Enterprises LimitedOntic Finserve LimitedChemcrux Enterprises LimitedManomay TexAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search